Intensive Care Unit

Nadas' Pediatric Cardiology

Volumn , Issue , 2006, Pages 303-321

  Wessel, David L ^a,b,c   Laussen, Peter C ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Department of Cardiology ^*  (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 59449095661     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-2390-6.50023-4     Document Type: Chapter

References (62)

1. AC Chang (2002) How to start and sustain a successful pediatric cardiac intensive care program: A combined clinical and administrative strategy. Pediatr Crit Care Med 3 107.
2. K Brown, AE Johnston and AW Conn (1966) Respiratory insufficiency and its treatment following paediatric cardiovascular surgery. Can Anaesth Soc J 13 342.
3. AR Castaneda, JE Mayer Jr., RA Jonas, et al. (1989) The neonate with critical congenital heart disease: repair: a surgical challenge. J Thorac Cardiovasc Surg 98(5 Pt 2), 869.
4. WF Friedman and BL George (1985) Treatment of congestive heart failure by altering loading conditions of the heart. J Pediatr 106 697.
5. WF Friedman (1972) The intrinsic physiologic properties of the developing heart. Prog Cardiovasc Dis 15 87.
6. TE Romero and WF Friedman (1979) Limited left ventricular response to volume overload in the neonatal period: a comparative study with the adult animal. Pediatr Res 13 910.
7. AN Mills and SG Haworth (1991) Greater permeability of the neonatal lung. Postnatal changes in surface charge and biochemistry of porcine pulmonary capillary endothelium. J Thorac Cardiovasc Surg 101 909.
8. TF Feltes and TN Hansen (1989) Effects of an aorticopulmonary shunt on lung fluid balance in the young lamb. Pediatr Res 26 94.
9. VM Reddy, DB McElhinney, T Sagrado, et al. (1999) Results of 102 cases of complete repair of congenital heart defects in patients weighing 700 to 2500 grams. J Thorac Cardiovasc Surg 117 324.
10. P Lang, CW Chipman and M Siden (1982) Early assessment of hemodynamic status after repair of tetralogy of Fallot: a comparison of 24 hour and one year postoperative data in 98 patients. Am J Cardiol 58 795.
11. G Wernovsky, D Wypij, RA Jonas, et al. (1995) Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92 2226.
12. ND Bridges, JE Mayer Jr., JE Lock, et al. (1992) Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation 86 1762.
13. MS Lemler, WA Scott, SR Leonard, et al. (2002) Fenestration improves clinical outcome of the Fontan procedure: a prospective, randomized study. Circulation 105 207.
14. DJ Bohn, CS Poirer and JF Demonds (1980) Efficacy of dopamine, dobutamine, and epinephrine during emergence from cardiopulmonary bypass in children. Crit Care Med 8 367.
15. DL Wessel (2001) Managing low cardiac output syndrome after congenital heart surgery. [Review]. Critical Care Medicine 29(Suppl), S220.
16. DM Habib, JF Padbury, NG Anas, et al. (1992) Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients. Crit Care Med 20 601.
17. EB Rosenzweig, TJ Starc, JM Chen, et al. (1999) Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 100 182.
18. J Caspi, JG Coles, LN Benson, et al. (1991) Age-related response to epinephrine-induced myocardial stress: a functional and ulstrastructural study. Circulation 84(Suppl), III-394.
19. J Caspi, JG Coles, LN Benson, et al. (1993) Effects of high plasma epinephrine and Ca2+ concentrations on neonatal myocardial function after ischemia. J Thorac Cardiovasc Surg 105 59.
20. JM Bailey, BE Miller, W Lu, et al. (1999) The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesth 90 1012.
21. AC Chang, AM Atz, G Wernovsky, et al. (1995) Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 23 1907.
22. TM Hoffman, G Wernovsky, AM Atz, et al. (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107 996.
23. R Mainwaring, J Lamberti, J Nelson, et al. (1997) Effects of tri-iodothyronine supplementation following modified Fontan procedure. Cardiol Young 7 194.
24. M Bettendorf, KG Schmidt, J Grulich-Henn, et al. (2000) Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 356 529.
25. D Chowdhury, VA Parnell, K Ojamaa, et al. (1999) Usefulness of triiodothyronine (T3) treatment after surgery for complex congenital heart disease in infants and children. Am J Cardiol 84 1107.
26. WS Colucci, U Elkayam, DP Horton, et al. (2000) Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. [erratum appears in N Engl J Med 2000;343:1504]. New England Journal of Medicine 343 246.
27. RM Mills, TH LeJemtel, DP Horton, et al. (1999) Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group. J Am Coll Cardiol 34 155.
28. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF): Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.[see comment][erratum appears in JAMA;288:577, 2002.]. JAMA 287 1531.
29. CW Yancy, MT Saltzberg, RL Berkowitz, et al. (2004) Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial). Am J Cardiol 94 595.
30. M Turanlahti, T Boldt, T Palkama, et al. (2004) Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Pediatr Crit Care Med 5 457.
31. J Janousek, P Vojtovic, B Hucin, et al. (2001) Resynchronization pacing is a useful adjunct to the management of acute heart failure after surgery for congenital heart defects. Am J Cardiol 88 145.
32. S Cullen, D Shore and A Redington (1995) Characterization of right ventricular diastolic performance after complete repair of tetralogy of Fallot. Restrictive physiology predicts slow postoperative recovery. Circulation 91 1782.
33. AN Redington, D Penny and ML Rigby (1992) Antegrade diastolic pulmonary arterial flow as a marker of right ventricular restriction after complete repair of pulmonary atresia with intact ventricular septum and critical pulmonary valve stenosis. Cardiol Young 2 382.
34. DL Wessel (2001) Current and future strategies in the treatment of childhood pulmonary hypertension. Prog Ped Cardiol 12 289.
35. WH Drummond, GA Gregory, MA Heymann, et al. (1981) The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J Pediatr 98 603.
36. RJ Barst, LJ Rubin, WA Long, et al. (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. [see comment]. N Engl J Med 334 296.
37. HI Palevsky, W Long, J Crow, et al. (1990) Prostacyclin and acetylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension. Circulation 82 2018.
38. EB Rosenzweig, D Kerstein and RJ Barst (1999) Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 99 1858.
39. G Zobel, D Dacar, S Rodl, et al. (1995) Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets. Pediatr Res 38 198.
40. E Petrossian, AJ Parry, VM Reddy, et al. (1999) Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow. J Thorac Cardiovasc Surg 117 314.
41. CG Frostell, MD Fratacci, JC Wain, et al. (1991) Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83 2038.
42. RF Furchgott and JV Zawadzki (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 373.
43. LJ Ignarro, GM Buga, KS Wood, et al. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84 9265.
44. AM Atz and DL Wessel (1997) Inhaled nitric oxide in the neonate with cardiac disease. Semin Perinatol 21 441.
45. DL Wessel, I Adatia, TM Giglia, et al. (1993) Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 88(5 Pt 1), 2128.
46. D Journois, P Pouard, P Mauriat, et al. (1994) Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 107 1129.
47. AP Goldman, RE Delius, JE Deanfield, et al. (1996) Pharmacological control of pulmonary blood flow with inhaled nitric oxide after the fenestrated Fontan operation. Circulation 94(Suppl), II44.
48. OI Miller, SF Tang, A Keech, et al. (2000) Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 356 1464.
49. I Adatia, AM Atz and DL Wessel (2005) Inhaled nitric oxide does not improve systemic oxygenation after bidirectional superior cavopulmonary anastomosis. J Thorac Cardiovasc Surg 129 217.
50. I Adatia, AM Atz, RA Jonas, et al. (1996) Diagnostic use of inhaled nitric oxide after neonatal cardiac operations. J Thorac Cardiovasc Surg 112 1403.
51. AM Atz and DL Wessel (1999) Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 91 307.
52. BW Duncan, V Hraska, RA Jonas, et al. (1999) Mechanical circulatory support in children with cardiac disease. J Thorac Cardiovasc Surg 117 529.
53. Extracorporeal Life Support Organization (2002) ECLS Registry Report: International Summary Ann Arbor, MI: Extracorporeal Life Support Organization
54. Wessel D, Almodovar M, Laussen P. Intensive care management of cardiac patients on extracorporeal membrane oxygenation. In: Duncan B (ed). Mechanical Support for Cardiac and Respiratory Failure. 2000, pp 75–111.
55. BW Duncan, AE Ibrahim, V Hraska, et al. (1998) Use of rapid-deployment extracorporeal membrane oxygenation for the resuscitation of pediatric patients with heart disease after cardiac arrest. J Thorac Cardiovasc Surg 116 305.
56. J Jenkins, A Lynn, J Edmonds, et al. (1985) Effects of mechanical ventilation on cardiopulmonary function in children after open-heart surgery. Crit Care Med 13 77.
57. JL Robotham, W Lixfeld, L Holland, et al. (1980) The effects of positive end-expiratory pressure on right and left ventricular performance. Am Rev Respir Dis 121 677.
58. MR Pinsky, WR Summer, RA Wise, et al. (1983) Augmentation of cardiac function by elevation of intrathoracic pressure. J Appl Physiol 54 950.
59. JW Newburger, RA Jonas, G Wernovsky, et al. (1993) Perioperative neurologic effects of hypothermic arrest during infant heart surgery. The Boston Circulatory Arrest Study. N Engl J Med 329 1057.
60. JM Costello, CL Backer, A de Hoyos, et al. (2003) Aprotinin reduces operative closure time and blood product use after pediatric bypass. Ann Thorac Surg 75 1261.
61. M Elliott (1999) Modified ultrafiltration and open heart surgery in children. Paediatr Anaesth 9 1.
62. G Paret, AJ Cohen, DJ Bohn, et al. (1992) Continuous arteriovenous hemofiltration after cardiac operations in infants and children. J Thorac Cardiovasc Surg 104 1225.